Font Size: a A A
Keyword [CD20~+]
Result: 101 - 120 | Page: 6 of 7
101. Recombinant Anti-CD20 Monoclonal Antibody ELISA Methodology Establishment And Application
102. Comparative Research On 99mTc-rituximab And 99mTc-sulfur Colloid In Sentinel Lymph Node Imaging Of Breast Cancer
103. Anti-CD20 MAb Effectively Depletes CD20-expressing T Cells In Type 1 Diabetic Patients
104. A Comparative Research On Pharmacokinetics And Pharmacodynamics Of A Humanized Anti-CD20 MAb Basing On Comprehensive Bioanalytical Methods
105. Safety And Efficacy Of CAR-T Cells In Patients With Refractory Or Relapsed B-cell Lymphoma
106. Effects Of Toll-like Receptor 4 Gene Knockout On CD20~+ Cells And CD68~+ Cells In Myocardial Ischemia
107. Expression Levels Of CD20 And CD3 In Labial Gland Tissues In Different Locations Of Sjogren''s Syndrome And Their Clinical Significance
108. The Clinical Efficacy In Predicting CD20 Positive Of Childhood Acute Lymphoblastic LeukemiaTreated With CCLG-ALL 2008 Protocol
109. Correlation Between Expression Of CD3,CD20 And CD68 In Renal Interstitium Of IgA Nephropathy And Disease Severity
110. Expression Characteristics And Clinical Significance Of PD-1/PD-ls In Peripheral Blood CD19~+B Cells Of Patients With Systemic Lupus Erythematosus
111. Efficacy And Safety Of Rituximab For Patients With Immune Thrombocytopenia:A Systematic Review And Meta-analysis
112. The Study Of CAR Modified NK-92 Cells Targeting CD20~+ Lymphoma In Vitro
113. Analysis Of Clinical Characteristics Of CD20 Negative Diffuse Large B-cell Lymphoma
114. Meta-analysis Of The Effect Of Anti-CD20 Monoclonal Antibody Maintenance Therapy On Survival Of Follicular Lymphoma Patients After Different First-line Induction Regimens
115. Molecular analysis of the CD20 oligomeric complex and its response to B cell antigen receptor activation
116. Enhancing rituximab therapy: Analyzing the interaction between rituximab and the human complement pathway
117. Drug-free macromolecular therapeutics for treatment of B-cell malignancies
118. Systemic Analysis Of B Cells And The Specific Mechanisms Of CD20hiB Cells In The Pathogenesis Of Systemic Lupus Erythematosus
119. Investigation Of The Clinical And Immunological Characteristic Of Ezcematous Psoriasis
120. Clinical Features And Survival Analysis Of Chemotherapy Combined With Immunotherapy Of Children With B-NHL CD20(+)
  <<First  <Prev  Next>  Last>>  Jump to